Invests in
Sectors:
Locations:
Min Investment:
$5,000,000.00Max Investment:
$10,000,000.00Target Investment:
$7,500,000.00
Skills
Education
- Uo
Lists including Beat
Work Experience
2006
Managing Director Novartis Venture Fund
2021
Principal Novartis Venture Fund
2015 - 2021
Global Franchise Head Critical Care ai
2014 - 2015
General Manager Serelaxin
2013 - 2014
Assistant to Head of Pharma Division
2011 - 2013
Head Marketing General Medicines
2009 - 2011
Associate Director Valturna
2008 - 2009
Regional Director West CV Specialty Sales
2006 - 2008
2021
Member Board of Directors
2021
SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research.
2020
Chairman of the Board
2020
Rappta Therapeutics is a late preclinical stage biopharmaceutical company. We are working on a first-in-class series of anti-cancer molecular glues that reactivate a key tumor suppressor, protein phosphatase 2A (PP2A).
2019
Member Board of Directors
2019
Vivet Therapeutics is a clinical-stage emerging biotechnology company developing novel gene therapy treatments for rare, inherited metabolic diseases.
2017
Member Board of Directors
2022
The UZH Life Sciences Fund (LSF) provides early financing for life sciences, biotech and med tech spin-offs whose business ideas are based on intellectual property resulting from research done at the University of Zurich. The aim is to accelerate the development process of such spin-offs in the early phase of their life cycle (when fund raising can be long and/or difficult), and thus accelerate the transfer of UZH research findings into practice, which ultimately benefits patients and the public at large.
Chairman of the Board
2020 - 2022
Member Board of Directors
2017 - 2020
2019 - 2020
Member Board of Directors
2019 - 2020
Binx Health is creating new categories of healthcare solutions that put on-demand testing where people need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer digital offerings, Binx is redefining "convenient care" for the modern consumer.
2017 - 2019
Member Board of Directors
2017 - 2019
A pioneering therapeutic approach harnessing the power of protein aggregation.
1999 - 2001
Senior Associate
1999 - 2001
1995 - 1998
Resident in Cardiovascular Surgery
1995 - 1998
Cardiovascular Surgery